Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-11 Sale | 2022-10-13 8:52 pm | AVENUE THERAPEUTICS Inc | ATXI | InvaGen Pharmaceuticals Inc. 10% Owner | 388,888 | $7.714 | $2,999,882 | 0 (Indirect Direct) | View |
| 2021-09-15 Sale | 2021-09-15 4:03 pm | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 7,160 | $1.62 | $11,599 | 65,252 (Direct) | View |
| 2021-05-06 Purchase | 2021-05-07 08:02 am | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 2,500 | $3.99 | $9,975 | 134,724 (Direct) | View |
| 2020-08-20 Sale | 2020-08-21 4:15 pm | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 3,840 | $12.13 | $46,579 | 57,412 (Direct) | View |
| 2020-03-09 Purchase | 2020-03-10 4:42 pm | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 3,389 | $7.9615 | $26,982 | 61,252 (Direct) | View |
| 2020-02-26 Purchase | 2020-03-02 08:10 am | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 2,561 | $8.2333 | $21,086 | 122,224 (Direct) | View |
| 2020-02-25 Purchase | 2020-02-25 4:55 pm | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 1,200 | $9.09 | $10,908 | 57,863 (Direct) | View |
| 2020-02-25 Purchase | 2020-02-25 4:53 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 10,000 | $9.31 | $93,100 | 119,663 (Direct) | View |
| 2019-09-12 Purchase | 2019-09-16 4:16 pm | AVENUE THERAPEUTICS Inc | ATXI | Ingram Elizabeth Garrett Director | 16,000 | $6.27 | $100,320 | 16,000 (Direct) | View |
| 2019-08-08 Sale | 2019-08-12 4:19 pm | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 4,688 | $5.5896 | $26,204 | 56,663 (Direct) | View |
| 2019-06-17 Purchase | 2019-06-19 4:54 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 5,000 | $5.86 | $29,300 | 99,663 (Direct) | View |
| 2019-04-15 Purchase | 2019-04-15 4:33 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 1,000 | $4.52 | $4,520 | 94,663 (Direct) | View |
| 2019-03-28 Purchase | 2019-03-29 4:33 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 2,000 | $5.11 | $10,220 | 93,663 (Direct) | View |
| 2019-02-25 Purchase | 2019-02-25 4:13 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 5,000 | $5.46 | $27,300 | 91,663 (Direct) | View |
| 2019-02-04 Purchase | 2019-02-06 4:31 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 8,850 | $5.8807 | $52,045 | 86,663 (Direct) | View |
| 2019-01-30 Purchase | 2019-02-01 12:48 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 650 | $5.91 | $3,842 | 77,813 (Direct) | View |
| 2019-01-28 Purchase | 2019-01-30 4:18 pm | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 10,000 | $5.8999 | $58,999 | 77,163 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-31 Option Award | 2023-01-04 5:49 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | Fortress Biotech Inc. 10% Owner | 322,225 | $0 | 811,561 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 4:26 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | KRANZLER JAY D Director | 69,020 | $0 | 133,683 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 4:26 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 69,020 | $0 | 183,744 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 4:24 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | Oltmans Curtis Gale Director | 49,020 | $0 | 49,020 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-20 5:08 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | Lu Lucy President CEO | 411,616 | $0 | 748,949 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-20 5:07 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 100,505 | $0 | 165,757 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-16 5:09 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | KRANZLER JAY D Director | 10,000 | $0 | 84,663 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-16 5:09 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 10,000 | $0 | 132,224 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-13 4:32 pm | N/A 2025-02-12 | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 22,727 | $0 | 50,505 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-13 4:31 pm | N/A 2025-02-12 | AVENUE THERAPEUTICS Inc | ATXI | Lu Lucy President CEO | 110,959 | $0 | 246,576 (Direct) | View |
| 2019-02-08 Ownership | 2019-12-31 06:01 am | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | InvaGen Pharmaceuticals Inc. 10% Owner | 0 | $0 | 10,142,379 (Direct) | View |
| 2019-08-27 Option Award | 2019-08-28 4:17 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | KRANZLER JAY D Director | 10,000 | $0 | 74,663 (Direct) | View |
| 2019-08-27 Option Award | 2019-08-28 4:17 pm | N/A N/A | AVENUE THERAPEUTICS Inc | ATXI | Herskowitz Neil Director | 10,000 | $0 | 109,663 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 4:42 pm | N/A 2024-06-03 | AVENUE THERAPEUTICS Inc | ATXI | Vazzano Joseph Walter Chief Financial Officer | 27,778 | $0 | 27,778 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 4:41 pm | N/A 2024-06-03 | AVENUE THERAPEUTICS Inc | ATXI | Lu Lucy President CEO | 135,617 | $0 | 135,617 (Direct) | View |